Miklós Békés
- Molecular Biology top 2%
- Oncology top 2%
- Infectious Diseases top 5%
- Hematology top 5%
- Immunology top 10%
- Co-authors
- David R. LangleyCraig M. CrewsTony T. HuangMarcin DrągGuy S. SalvesenWioletta RutShaun K. OlsenStephanie Patchett
- Topics
- Ubiquitin and proteasome pathways (15 papers)Peptidase Inhibition and Analysis (10 papers)Protein Degradation and Inhibitors (6 papers)
- Cited by
- OncologyMolecular BiologyHematology
- Partner nations
- United StatesPolandNetherlands
In The Last Decade
Miklós Békés
22 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Biology 2.7k
- Oncology 1.1k
- Infectious Diseases 347
- Hematology 302
- Immunology 282
Countries citing papers authored by Miklós Békés
This map shows the geographic impact of Miklós Békés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miklós Békés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miklós Békés more than expected).
Fields of papers citing papers by Miklós Békés
This network shows the impact of papers produced by Miklós Békés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miklós Békés. The network helps show where Miklós Békés may publish in the future.
Co-authorship network of co-authors of Miklós Békés
This figure shows the co-authorship network connecting the top 25 collaborators of Miklós Békés. A scholar is included among the top collaborators of Miklós Békés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miklós Békés. Miklós Békés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 2 | |
| 3 | PROTAC targeted protein degraders: the past is prologuebreakdown → | 1872 |
| 4 | 35 | |
| 5 | Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug designbreakdown → | 353 |
| 6 | 4 | |
| 7 | 33 | |
| 8 | 103 | |
| 9 | 52 | |
| 10 | 38 | |
| 11 | 59 | |
| 12 | 10 | |
| 13 | 133 | |
| 14 | 60 | |
| 15 | 40 | |
| 16 | 47 | |
| 17 | 62 | |
| 18 | 129 | |
| 19 | 30 | |
| 20 | 110 |
About Miklós Békés
Miklós Békés is a scholar working on Oncology, Molecular Biology and Parasitology, having authored 23 papers that have together received 3.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (15 papers), Peptidase Inhibition and Analysis (10 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Biology (2.7k citations) and Hematology (302 citations). Miklós Békés has collaborated with scholars based in United States, Poland and Netherlands. Frequent co-authors include David R. Langley, Craig M. Crews, Tony T. Huang, Marcin Drąg, Guy S. Salvesen, Wioletta Rut, Shaun K. Olsen, Stephanie Patchett, Zongyang Lv and Scott J. Snipas. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cell and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.